Differential effect of canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice

There has been a concern that sodium–glucose cotransporter 2 (SGLT2) inhibitors could reduce skeletal muscle mass and function. Here, we examine the effect of canagliflozin (CANA), an SGLT2 inhibitor, on slow and fast muscles from nondiabetic C57BL/6J mice. In this study, mice were fed with or witho...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Hiroko, Yokomizo, Hisashi, Nakamura, Shintaro, Izumi, Yoshihiro, Takahashi, Masatomo, Obara, Sachiko, Nakao, Motonao, Ikeda, Yosuke, Sato, Naoichi, Sakamoto, Ryuichi, Miyachi, Yasutaka, Miyazawa, Takashi, Bamba, Takeshi, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Diabetes & Metabolic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883489/
https://www.ncbi.nlm.nih.gov/pubmed/35048967
http://dx.doi.org/10.1042/BCJ20210700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883489/
https://www.ncbi.nlm.nih.gov/pubmed/35048967
http://dx.doi.org/10.1042/BCJ20210700

Ejemplares similares